Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Both vehicle types have fee trade-offs. This guide shows how expense ratios and additional costs stack up to help you pick the cheaper option.
28,162 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Investors often wonder if the memory chip darling Micron is still worth buying after a big run. This guide breaks dow...
Ethereum’s selloff tests whether the network’s neutrality-first model can shield value as leadership exits hit the Fo...
With inflation stubborn and growth resilient, traders are debating whether the Fed will hold rates in June or pivot l...
In a bold reprise of his thesis, Michael Saylor argues Bitcoin is the base layer for a new digital capital stack, pus...
As markets sway, a long-running dividend payer draws retirees seeking steady, rising income. PepsiCo's 50-plus years ...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
The NANC ETF, built to mirror congressional disclosure trades, is facing a tougher 2026 as interest rates move higher...
A major fund just boosted its stake in a struggling auto-parts retailer. This article breaks down what the move could...
When a billionaire like David Tepper reportedly sold stakes in Nvidia and Amazon, it raises questions for regular inv...
USC receives a $200 million gift from Mark Stevens and his wife to launch a campuswide AI initiative, marking one of ...
A new federal filing in Manhattan targets Tether, seeking the transfer of $344 million in frozen USDT linked to Iran’...